Compare SI & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SI | GLO |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.1M | 255.7M |
| IPO Year | 2025 | N/A |
| Metric | SI | GLO |
|---|---|---|
| Price | $13.58 | $5.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.60 | N/A |
| AVG Volume (30 Days) | 65.1K | ★ 170.5K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,626,000.00 | N/A |
| Revenue This Year | $48.42 | N/A |
| Revenue Next Year | $29.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 115.97 | N/A |
| 52 Week Low | $10.92 | $4.08 |
| 52 Week High | $17.94 | $5.18 |
| Indicator | SI | GLO |
|---|---|---|
| Relative Strength Index (RSI) | 44.24 | 57.10 |
| Support Level | $12.11 | $5.95 |
| Resistance Level | $14.05 | $6.08 |
| Average True Range (ATR) | 1.00 | 0.07 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 37.59 | 65.00 |
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.